Impact of body weight-based dosing of palonosetron and ondansetron on postoperative nausea and vomiting following laparoscopic sleeve gastrectomy: a randomized, double-blind study

References

• Kaloria A, Mohini Sen I, Saini V, et al. Palonosetron-dexamethasone versus ondansetron-dexamethasone to prevent postoperative nausea and vomiting undergoing laparoscopic sleeve gastrectomy: a preliminary, randomized, double blinded study. Indian J Clin Anaesth. 2017;4:523–529.
   Google Scholar
• Sridharan K, Sivaramakrishnan G. Drugs for preventing post-operative nausea and vomiting in patients undergoing laparoscopic cholecystectomy: network meta-analysis of randomized clinical trials and trial sequential analysis. Int J Surg. 2019;69:1–12.
   PubMed Web of Science ®Google Scholar
• Reddy GS, Manjusruthi B, Jyothsna G. Postoperative nausea and vomiting prophylaxis: a comparative study of ramosetron and palonosetron in patients undergoing laparoscopic cholecystectomy – a prospective randomized trial. Anesth Essays Res. 2019;13(1):68–72.
   PubMedGoogle Scholar
• Didehvar S, Viola-Blitz JD, Franco MHL, et al. Randomized, double blind study to evaluate the efficacy of palonosetron with dexamethasone versus palonosetron alone for prevention of post-operative nausea and vomiting in subjects undergoing bariatric surgeries with high emetogenic risk. Open Anesthesiol J. 2013;7:30–33.
   Google Scholar
• Aydin A, Kaçmaz M, Boyaci A. Comparison of ondansetron, tropisetron, and palonosetron for the prevention of postoperative nausea and vomiting after Middle ear surgery. Curr Ther Res Clin Exp. 2019;91:17–21.
   PubMed Web of Science ®Google Scholar
• Bhalla J, Baduni N, Bansal P. Comparison of palanosetron with ondansetron for postoperative nausea and vomiting in patients undergoing laparoscopic cholecystectomy under general anesthesia. J Minim Access Surg. 2015;11(3):193–197.
   PubMed Web of Science ®Google Scholar
• Sharma S, Khanna S, Das J, et al. A randomized study to compare palonosetron with ondansetron for prevention of postoperative nausea and vomiting following middle ear surgeries. J Anaesthesiol Clin Pharmacol. 2019;35(2):182–187.
   PubMed Web of Science ®Google Scholar
• Rajnikant K, Bhukal I, Kaloria N, et al. Comparison of palonosetron and dexamethasone with ondansetron and dexamethasone to prevent postoperative nausea and vomiting in patients undergoing laparoscopic cholecystectomy. Anesth Essays Res. 2019;13(2):317–322.
   PubMedGoogle Scholar
• Ienca R, Giardiello C, Scozzarro A, et al. Improving nausea and vomiting post-elipse balloon: a novel single-dose regimen of 300 mg netupitant/0.5 mg palonosetron hydrochloride. Obes Surg. 2019;29(9):2952–2956.
   PubMed Web of Science ®Google Scholar
• Gouveia de Araujo Ferreira N, Cavalcanti IL, Assad AR, et al. A prospective, randomized, double-blind trial to compare body weight-adjusted and fixed doses of palonosetron for preventing postoperative nausea and vomiting in obese female patients. PLoS One. 2020;15(1):e0227490.
   PubMed Web of Science ®Google Scholar
• Lee S, Kim I, Pyeon T, et al. Population pharmacokinetics of palonosetron and model-based assessment of dosing strategies. J Anesth. 2019;33(3):381–389.
   PubMed Web of Science ®Google Scholar
• Koivuranta M, Läärä E, Snåre L, et al. A survey of postoperative nausea and vomiting. Anaesthesia. 1997;52(5):443–449.
   PubMed Web of Science ®Google Scholar
• Eberhart LH, Högel J, Seeling W, et al. Evaluation of three risk scores to predict postoperative nausea and vomiting. Acta Anaesthesiol Scand. 2000;44(4):480–488.
   PubMed Web of Science ®Google Scholar
• O'Brien BJ, Rusthoven J, Rocchi A, et al. Impact of chemotherapy-associated nausea and vomiting on patients’ functional status and on costs: survey of five Canadian centres. CMAJ. 1993;149(3):296–302.
   PubMed Web of Science ®Google Scholar
• Poon M, Dennis K, DeAngelis C, et al. Symptom clusters of gastrointestinal cancer patients undergoing radiotherapy using the functional living index-emesis (FLIE) quality-of-life tool. Support Care Cancer. 2015;23(9):2589–2598.
   PubMed Web of Science ®Google Scholar
• Wu X, Wu J, Tong G, et al. Efficacy of olanzapine-triple antiemetic regimen in patients with gastrointestinal tumor and high risk of chemotherapy-ınduced nausea and vomiting receiving moderately emetogenic chemotherapy: a retrospective study. Cancer Manag Res. 2020;12:6575–6583.
   PubMed Web of Science ®Google Scholar
• Li Q, Wu Y, Wang W, et al. Effectiveness and safety of combined neurokinin-1 antagonist aprepitant treatment for multiple-day anthracycline-induced nausea and vomiting. Curr Probl Cancer. 2019;43(6):100462.
   PubMed Web of Science ®Google Scholar
• Cho E, Kim DH, Shin S, et al. Efficacy of palonosetron-dexamethasone combination versus palonosetron alone for preventing nausea and vomiting related to opioid-based analgesia: a prospective, randomized, double-blind trial. Int J Med Sci. 2018;15(10):961–968.
   PubMed Web of Science ®Google Scholar
• Fonseca NM, Pedrosa LR, Melo N, et al. Efeito da palonosetrona, ondansetrona e dexametasona na prevenção de náusea e vômito pós‐operatório em videocolecistectomia com anestesia venosa total com propofol‐remifentanil – ensaio clínico randomizado duplo cego [effect of palonosetron, ondansetron and dexamethasone in the prevention of postoperative nausea and vomiting in video cholecystectomy with total venous anesthesia with propofol-remifentanil – randomized clinical trial]. Braz J Anesthesiol. 2020;70(5):464–470.
   PubMedGoogle Scholar
• Srivastava VK, Khan S, Agrawal S, et al. Comparação entre palonosetrona‐dexametasona e ondansetrona‐dexametasona na prevenção de náuseas e vômitos no pós‐operatório de cirurgia do ouvido médio: estudo clínico randomizado [comparison of palonosetron-dexamethasone and ondansetron-dexamethasone for prevention of postoperative nausea and vomiting in Middle ear surgery: a randomized clinical trial]. Rev Bras Anestesiol. 2020;70(5):477–483.
   Web of Science ®Google Scholar
• Campos GO, de Jesus Martins M, Jesus GN, et al. Palonosetron versus ondansetron for prevention of nausea and vomiting after total abdominal hysterectomy under spinal anesthesia with intrathecal morphine: a double-blind, randomized controlled trial. BMC Anesthesiol. 2019;19(1):159.
   PubMed Web of Science ®Google Scholar
• Tahir S, Mir AA, Hameed A. Comparison of palonosetron with granisetron for prevention of postoperative nausea and vomiting in patients undergoing laparoscopic abdominal surgery. Anesth Essays Res. 2018;12:636–643.
   PubMedGoogle Scholar
• Yoo JH, Jeon IS, Chung JW, et al. Comparison of palonosetron and ondansetron to prevent postoperative nausea and vomiting in women using intravenous patient-controlled analgesia. Anesth Pain Med (Seoul). 2020;15(1):28–34.
   PubMedGoogle Scholar
• Kovac AL, Eberhart L, Kotarski J, et al. A randomized, double-blind study to evaluate the efficacy and safety of three different doses of palonosetron versus placebo in preventing postoperative nausea and vomiting over a 72-hour period. Anesth Analg. 2008;107(2):439–444.
   PubMed Web of Science ®Google Scholar
• Kang JH, Kwon JH, Lee YG, et al. Ramosetron versus palonosetron in combination with aprepitant and dexamethasone for the control of highly-emetogenic chemotherapy-ınduced nausea and vomiting. Cancer Res Treat. 2020;52(3):907–916.
   PubMed Web of Science ®Google Scholar
• Yee C, Drost L, Zhang L, et al. Impact of radiation-induced nausea and vomiting on quality of life. Support Care Cancer. 2018;26(11):3959–3966.
   PubMed Web of Science ®Google Scholar
• Ganesh V, Chan S, Zhang L, et al. Management of radiation-induced nausea and vomiting with palonosetron in patients with pre-existing emesis: a pilot study. Ann Palliat Med. 2018;7(4):385–392.
   PubMed Web of Science ®Google Scholar
• Pierre S, Benais H, Pouymayou J. Apfel’s simplified score may favourably predict the risk of postoperative nausea and vomiting. Can J Anaesth. 2002;49(3):237–242.
   PubMed Web of Science ®Google Scholar